Skip to main content
. 2009 Jul 8;2009(3):CD007357. doi: 10.1002/14651858.CD007357.pub2
Summary of results B: Participants with at least one adverse event
Dose Studies Participants Etodolac (%) Placebo (%) NNH (95%CI)
50 mg 4 320 8 6 not calculated
100 mg 5 459 11 7 not calculated
200 mg 7 633 22 17 not calculated
400 mg 4 310 28 34 not calculated